Join
Live feed
·
INSIDERFilingvia Quantisnow
Rocket Pharmaceuticals Inc. logo

CEO Shah Gaurav sold $14,523 worth of shares (2,253 units at $6.45), decreasing direct ownership by 0.29% to 786,806 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RCKT· Rocket Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RCKT (Rocket Pharmaceuticals Inc.) and more on Quantisnow.